Message from the Chair – Spring 2020


Message from the Chair – This New Year brings great anticipation for progress in the treatment of melanoma and skin cancers, like cutaneous squamous cell carcinoma (cSCC). We have been anxiously awaiting provincial listings for adjuvant therapies for melanoma – in particular the adjuvant (for stage III fully resected patients), targeted therapy combination of Dabrafenib and Trametinib, and the adjuvant immunotherapies – Pembrolizumab and Nivolumab.

Islington Golf Club

Thank you to the Men’s Section of Islington Golf Club for their generous contribution! On behalf of MNC, we would…


Sign up to receive the latest news from Melanoma Network of Canada